Results 271 to 280 of about 95,754 (365)
Systemic inflammatory response index: a novel predictor for cardiovascular disease risk in patients with primary biliary cholangitis. [PDF]
Li Y, Zhu N, Li X.
europepmc +1 more source
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo +11 more
wiley +1 more source
The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. [PDF]
Abuelazm M +7 more
europepmc +1 more source
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives. [PDF]
Romeo M +10 more
europepmc +1 more source
Abstract Objectives To describe the clinical and laboratory characteristics and outcomes of pediatric hepatopulmonary syndrome (HPS) secondary to portal hypertension (PH) in Brazil. Methods Fifty‐four pediatric patients diagnosed with PH and HPS according to the European Respiratory Society criteria were included in this multicenter retrospective study.
Leticia Drumond Alberto +14 more
wiley +1 more source
Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. [PDF]
Zingone F +6 more
europepmc +1 more source

